Roper Technologies Inc (ROP)

ROP (NYSE:Industrial) EQUITY
pos +0.00
Today's Range: 173.60 - 174.89 | ROP Avg Daily Volume: 375,600
Last Update: 07/02/15 - 4:03 PM EDT
Volume: 0
YTD Performance: 11.67%
Open: $0.00
Previous Close: $174.02
52 Week Range: $137.34 - $178.92
Oustanding Shares: 100,521,210
Market Cap: 17,549,998,054
6-Month Chart
TheStreet Ratings Grade for ROP
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 4 4 4
Moderate Buy 1 1 1 1
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.00 2.00 2.00
Latest Dividend: 0.25
Latest Dividend Yield: 0.57%
Dividend Ex-Date: 07/08/15
Price Earnings Ratio: 26.94
Price Earnings Comparisons:
ROP Sector Avg. S&P 500
26.94 27.00 26.10
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.87% 19.91% 79.03%
Revenue 9.60 0.27 0.08
Net Income 20.00 0.51 0.15
EPS 19.20 0.45 0.13
Earnings for ROP:
Revenue 3.55B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.63 $1.72 $6.87 $7.47
Number of Analysts 5 4 6 6
High Estimate $1.65 $1.75 $7.00 $7.70
Low Estimate $1.59 $1.70 $6.75 $7.15
Prior Year $1.56 $1.55 $6.42 $6.87
Growth Rate (Year over Year) 4.62% 10.97% 7.04% 8.76%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
You could throw darts at financials and health care and win. 
Another heavy week of earnings and data on tap.
Nov 05, 2014 | 7:46 AM EST
ROP was downgraded from Overweight to Neutral, JP Morgan said. Valuation call, as the stock has outperformed its peers year-to-date.
Oct 29, 2013 | 8:22 AM EDT
Shares of ROP now seen reaching $131, Barclays said. Estimates also lowered on difficult quarter and lowered outlook. Overweight rating...
Jan 29, 2013 | 8:12 AM EST
Shares of ROP now seen reaching $130, Oppenheimer said. Estimates also raised on operating leverage. Outperform rating.
Nov 16, 2012 | 7:53 AM EST
ROP was upgraded to Buy from Neutral, Citigroup said. $130 price target. Compelling growth story. 
Oct 26, 2012 | 8:24 AM EDT
Shares of ROP now seen reaching $120, Oppenheimer said. Portfolio evolution shines. Perform rating.
Apr 24, 2012 | 8:12 AM EDT
Shares of ROP now seen reaching $110, Oppenheimer said. Estimates also raised on continual commercialization of new applications. Perfo...
Apr 24, 2012 | 6:48 AM EDT
ROP was downgraded from Outperform to Neutral, Robert Baird said. $105 price target. Company trades at a 40% premium to its peers. ...
This trio of smaller industrial names offers an alternative to their large-cap brethren.

Columnist Conversations

If the adage that the market hates uncertainty, then a "yes" vote just brings further negotiations. Anyone who...
So, why did the markets really get pasted on Monday? I believe it had more to do with the Greek politicians w...
Aetna (AET) is paying .8375 shares plus $125 cash for Humana (HUM). This along with Cigna (CI)-Anthem (ANTM) t...
"Ain't no time to hate, barely time to wait, Wo, oh, what I want to know, where does the time go?" Enjoy July ...


News Breaks

Powered by

Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.